Modification by spychotropic drugs of the cyclic adenosine monophosphate response to norepinephrine in rat brain.
D000227:Adenine Nucleotides / Q000378:metabolism*; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D001933:Brain Stem / Q000187:drug effects* / Q000378:metabolism; D002746:Chlorpromazine / Q000494:pharmacology*; D000242:Cyclic AMP / Q000378:metabolism; D003986:Dibenzocycloheptenes / Q000494:pharmacology*; D006220:Haloperidol / Q000494:pharmacology*; D007031:Hypothalamus / Q000187:drug effects* / Q000378:metabolism; D066298:In Vitro Techniques; D009638:Norepinephrine / Q000494:pharmacology*; D010293:Pargyline / Q000494:pharmacology; D011437:Propylamines / Q000494:pharmacology; D051381:Rats; D013454:Sulfoxides / Q000494:pharmacology
D000227:Adenine Nucleotides; D000928:Antidepressive Agents; D003986:Dibenzocycloheptenes; D011437:Propylamines; D013454:Sulfoxides; D010293:Pargyline; D000242:Cyclic AMP; D006220:Haloperidol; D002746:Chlorpromazine; D009638:Norepinephrine